Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-04

Clinical Trial Update: Investigation of the Effects of Oxidized Antigens on the T-Cell Response and the Epigenetic Reprogramming of Neutrophils in Lung Diseases - OXIGENE -

View source ↗

Summary

Clinical trial from Research Center Borstel (OXIGENE) investigates oxidized antigens' effects on T-cell responses and epigenetic reprogramming of neutrophils in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OXIGENE oxidized antigens

Snippet

Sponsor: Research Center Borstel | Conditions: Asthma, COPD | Status: NOT_YET_RECRUITING